AUS
NZ
UK
CA
USA
IND
Healt
Why are Microba Life Sciences’ (ASX:MAP) shares up 68%?
November 29, 2022 02:37 PM AEDT| By Sonal GoyalMicroba Life Sciences’ share price shot up by 68% on Tuesday after the company shared that Sonic has bought 19.99% stake in the company.
Healius’ (ASX:HLS) revenue falls by 31% in YTD FY23;here’s why
November 28, 2022 01:38 PM AEDT| By Sonal GoyalHealius share price drops after the company report a significant fall in the EBITDA and revenue during the four months to October 2022.
Up almost 17% in a month, what’s up with Nanosonics (ASX:NAN) lately?
November 25, 2022 01:00 PM AEDT| By Sonal GoyalNanosonic share price has been marking significant gain on the ASX although no price sensitive news was shared by the company.
How are PolyNovo (ASX:PNV) shares faring post A$30M equity raise?
November 23, 2022 01:45 PM AEDT| By RitwikaHow are PolyNovo (ASX:PNV) shares faring post A$30M equity raise?
Why are PolyNovo’s (ASX:PNV) shares under trading halt today?
November 22, 2022 02:26 PM AEDT| By RitwikaWhy are PolyNovo’s (ASX:PNV) shares under trading halt today?
Can virtual nursing be a saviour for overburdened healthcare system?
November 20, 2022 10:00 AM AEDT| By Aditi SarkarNurses were in high demand even before the COVID-19 pandemic, however, the new reform in aged care system has put pressure on the profession, giving rise to the need of virtual nurses.
How are Sonic’s (ASX:SHL) shares faring post AGM results?
November 17, 2022 02:57 PM AEDT| By TamnnaDespite reporting a successful FY22 with record revenue and earnings, shares of Sonic Healthcare were trading 0.216% lower, at AU$32.220 apiece, at 12:42 PM AEDT, 17 November.
AVITA (ASX:AVH) upgrades revenue guidance; shares up
November 11, 2022 01:19 PM AEDT| By Sonal GoyalShare price of AVITA surged significantly after the company shared its quarterly report and upgraded its guidance for FY22.
Ansell (ASX:ANN) expects lower earnings in FY23 shares fall
November 10, 2022 03:45 PM AEDT| By Sonal GoyalAnsell (ASX:ANN) has shared that its single use glove business is suffering.
Why is CSL (ASX:CSL) in news today?
November 10, 2022 11:44 AM AEDT| By TamnnaAustralia’s multinational biotechnology company CSL Limited’s (ASX:CSL) shares were trading on a positive note in the morning session today (10 November).
Medibank (ASX:MPL) says cybercriminals released stolen data online
November 09, 2022 01:14 PM AEDT| By Khushboo JoshiAustralian health insurer Medibank shared today that the hackers have posted stolen data on a dark web forum.
How are these three ASX-listed healthcare shares faring today?
November 07, 2022 03:56 PM AEDT| By RitwikaHow are these three ASX-listed healthcare shares faring today?
How are these ASX healthcare shares performing?
November 02, 2022 05:05 PM AEDT| By RitwikaHow are these ASX healthcare shares performing?
_11_01_2022_01_08_14_712396.jpg){kind=logo}
Why CSL’s (ASX:CSL) shares are in news?
November 01, 2022 11:57 AM AEDT| By TamnnaShares of CSL (ASX:CSL) were trading in the green on Tuesday despite no price-sensitive update shared by the company.
How are these ASX-listed healthcare stocks performing?
October 27, 2022 01:28 PM AEDT| By Sonal GoyalResearch and development in health care sector is an important componenet as it helps in remaining competitive globally.
Why did Cann Group’s (ASX:CAN) shares fall over 14% on ASX today?
October 25, 2022 04:44 PM AEDT| By RitwikaWhy did Cann Group’s (ASX:CAN) shares fall over 14% on ASX today?
Take a look at recent updates from ASX Healthtech stocks
October 25, 2022 02:35 PM AEDT| By Aditi Sarkar4DX, ADR, EIQ are some of the ASX-listed stocks specialising in medical technology.
SomnoMed (ASX:SOM) posts revenue rise, keeps FY23 guidance unchanged
October 25, 2022 01:15 PM AEDT| By TamnnaSomnoMed generated revenue of AU$18.5 million, which is 19% higher than the previous corresponding period (PCP), while its FY23 guidance remains unchanged.
Why is Telix Pharma (ASX:TLX) in news today?
October 14, 2022 01:55 PM AEDT| By Team Kalkine MediaTelix Pharmaceuticals’ Illuccix® has received approval from Health Canada. Illuccix® can be used to localise and stage, restage prostate cancer in men, as per Telix.
Why is Alterity Therapeutics (ASX:ATH) in news?
October 13, 2022 07:00 PM AEDT| By Team Kalkine MediaHREC has approved Alterity Therapeutics to conduct phase 2 clinical trials of the ATH434 agent in Australia. Following the approval, the price of Alterity shares increased by 7.692%.
Advertise your brand on Kalkine Media